Abstract |
Three treatment programs for Stage I and II mediastinal Hodgkin disease (established by laparotomy) were compared. Involved-field radiotherapy + MOPP gave a disease-free survival rate of 97%, significantly different from 62% and 55% for involved and extended fields, respectively. Corresponding survival figures of 97%, 88%, and 84% were not significantly different statistically due to salvage with radiotherapy and/or chemotherapy. Among patients given radiotherapy alone, the survival figure of 94% for limited mediastinal disease was significantly better than 63% for extensive mediastinal and hilar disease; corresponding disease-free figures of 72% and 35% were also significantly different. Constitutional symptoms were an important prognostic factor in disease-free survival following the use of involved fields; hilar disease was important only with large mediastinal masses. Most relapses were intrathoracic; MOPP alone salvaged only 47%. Treatment of Stage I and II Hodgkin disease should be based on symptoms, extent of mediastinal disease, and hilar involvement.
|
Authors | F B Hagemeister, L M Fuller, J A Sullivan, L North, W Velasquez, F G Conrad, P McLaughlin, J J Butler, C C Shullenberger |
Journal | Radiology
(Radiology)
Vol. 141
Issue 3
Pg. 783-9
(Dec 1981)
ISSN: 0033-8419 [Print] United States |
PMID | 6895415
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Procarbazine
- Mechlorethamine
- Vincristine
- Prednisone
|
Topics |
- Antineoplastic Combined Chemotherapy Protocols
- Drug Therapy, Combination
- Female
- Hodgkin Disease
(mortality, therapy)
- Humans
- Male
- Mechlorethamine
(therapeutic use)
- Mediastinal Neoplasms
(mortality, therapy)
- Neoplasm Staging
- Prednisone
(therapeutic use)
- Procarbazine
(therapeutic use)
- Prognosis
- Radiotherapy
(methods)
- Vincristine
(therapeutic use)
|